High-dose-rate brachytherapy (HDR-BT) in the treatment of lung cancer – Greatpoland Cancer Center experience

M. Kubaszewska, J. Skowronek, M. Kanikowski, A. Chichel, M. Fundowicz, G. Zwierzchowski, M. Dymnicka (Poznan, Poland)

Source: Annual Congress 2008 - Lung cancer and other malignant diseases involving the lungs
Session: Lung cancer and other malignant diseases involving the lungs
Session type: Thematic Poster Session
Number: 617
Disease area: Thoracic oncology

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
M. Kubaszewska, J. Skowronek, M. Kanikowski, A. Chichel, M. Fundowicz, G. Zwierzchowski, M. Dymnicka (Poznan, Poland). High-dose-rate brachytherapy (HDR-BT) in the treatment of lung cancer – Greatpoland Cancer Center experience. Eur Respir J 2008; 32: Suppl. 52, 617

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
High-dose-rate endobronchial brachytherapy (HD-BQT) in radical or palliative therapy for lung cancer
Source: International Congress 2014 – Diagnostic and therapeutic bronchoscopy: old and new techniques for interventional pulmonology
Year: 2014

Biological dosimetry in lung cancer (LC) patients treated with fractionated radiotherapy (RT)
Source: International Congress 2014 – Therapy of thoracic tumours: clinical trials and case series
Year: 2014


HDR endobronchial brachytherapy (HDR-BT) in the management of advanced lung cancer – comparison of different protocols
Source: Annual Congress 2008 - Lung cancer and other malignant diseases involving the lungs
Year: 2008

The rate of curative intended therapy against recurrent lung cancer before and after introduction of a CT-based follow-up program
Source: Annual Congress 2013 –Quality management in thoracic oncology
Year: 2013


Bronchoscopic high-dose-rate brachytherapy
Source: Eur Respir Mon; 2010: 48: 173–189
Year: 2010

Stereotactic ablative radiotherapy (SABR) in non-surgical non small cell lung cancer: Effects on respiratory function
Source: International Congress 2014 – Therapy of thoracic tumours: clinical trials and case series
Year: 2014


Primary lung cancer treated using radiofrequency ablation: Two year outcome data
Source: International Congress 2014 – Therapy of thoracic tumours: clinical trials and case series
Year: 2014

Site of first progression (PR) differs between stage III NSCLC patients treated with simultaneous radiochemotherapy (RTCT) and those treated with radiotherapy (RT) alone following induction chemotherapy (CT)
Source: International Congress 2014 – Advances in diagnosis and therapy of thoracic tumours
Year: 2014

Swedish Lung Cancer Radiation Study Group: The value of induction chemotherapy for radiotherapy response in patients with non-small cell lung cancer
Source: Annual Congress 2010 - Treatment of lung cancer
Year: 2010



Gene therapy with DDMC-p53 with or without cisplatin and microwave ablation. A future concept for local treatment in lung cancer
Source: International Congress 2015 – Diagnosis and therapy of lung cancer
Year: 2015

Surgical treatment outcomes on early-stages of non-small-cell lung cancer
Source: International Congress 2015 – Diagnosis and therapy of lung cancer
Year: 2015


Influence of neoadjuvant therapy to complication rate after surgery for primary lung cancer
Source: International Congress 2016 – Surgical strategy for complex diseases
Year: 2016

Brain metastatic recurrence following radically treated lung cancer; a retrospective analysis
Source: International Congress 2014 – Therapy of thoracic tumours: clinical trials and case series
Year: 2014


Results of stereotactic radiation therapy (SRT) on unique cerebral metastases from lung adenocarcinomas
Source: International Congress 2015 – Lung cancer therapy: clinical trials
Year: 2015

The risk of recurrence after intraoperative needle biopsy(INB) for preoperative undiagnosed early stage lung cancers
Source: International Congress 2014 – Improving diagnosis of thoracic tumours
Year: 2014

Our results of stereotactic radiotherapy in advanced stage lung cancer patients
Source: International Congress 2014 – Therapy of thoracic tumours: clinical trials and case series
Year: 2014

Accelereated hyperfractionated radiotherapy with uneven crushing daily dose in chemoradiation treatment of inoperable non-small cell lung cancer
Source: International Congress 2015 – Lung cancer therapy: clinical trials
Year: 2015


Single-institution experience of surgical management of metastasises of colorectal cancer in lungs: Lessons learned
Source: Annual Congress 2013 –Oncological thoracic surgery
Year: 2013

International trial of endobronchial implantation of electromagnetic fiducials for real-time tracking of lung tumors during radiotherapy (RT)
Source: Annual Congress 2013 –Interventional procedures for diagnosis of diffuse lung diseases and peripheral pulmonary lesions
Year: 2013

Oncologic emergencies in patients monitored for lung cancer in the Bab-El-Oued University Hospital
Source: International Congress 2015 – Thoracic oncology around the world: rare cases and local features
Year: 2015